Literature DB >> 2113891

Estimating costs in the economic evaluation of medical technologies.

B R Luce, A Elixhauser.   

Abstract

The complexities and nuances of evaluating the costs associated with providing medical technologies are often underestimated by analysts engaged in economic evaluations. This article describes the theoretical underpinnings of cost estimation, emphasizing the importance of accounting for opportunity costs and marginal costs. The various types of costs that should be considered in an analysis are described; a listing of specific cost elements may provide a helpful guide to analysis. The process of identifying and estimating costs is detailed, and practical recommendations for handling the challenges of cost estimation are provided. The roles of sensitivity analysis and discounting are characterized, as are determinants of the types of costs to include in an analysis. Finally, common problems facing the analyst are enumerated with suggestions for managing these problems.

Mesh:

Year:  1990        PMID: 2113891     DOI: 10.1017/s026646230000893x

Source DB:  PubMed          Journal:  Int J Technol Assess Health Care        ISSN: 0266-4623            Impact factor:   2.188


  25 in total

Review 1.  Socioeconomic evaluation in medicine in Europe. Core economic concepts.

Authors:  K Berger; T D Szucs
Journal:  Pharmacoeconomics       Date:  1999       Impact factor: 4.981

Review 2.  Common errors and controversies in pharmacoeconomic analyses.

Authors:  S Byford; S Palmer
Journal:  Pharmacoeconomics       Date:  1998-06       Impact factor: 4.981

Review 3.  Selective versus nonselective beta adrenoceptor antagonists in hypertension.

Authors:  L M Van Bortel; A J Ament
Journal:  Pharmacoeconomics       Date:  1995-12       Impact factor: 4.981

4.  Cost-effectiveness analysis of health care services, and concepts of distributive justice.

Authors:  G J van der Wilt
Journal:  Health Care Anal       Date:  1994-11

Review 5.  Evidence from cost-effectiveness research.

Authors:  Katia Noyes; Robert G Holloway
Journal:  NeuroRx       Date:  2004-07

Review 6.  Introducing economic evaluation as a policy tool in Korea: will decision makers get quality information? : a critical review of published Korean economic evaluations.

Authors:  Kun-Sei Lee; Werner B F Brouwer; Sang-Il Lee; Hye-Won Koo
Journal:  Pharmacoeconomics       Date:  2005       Impact factor: 4.981

Review 7.  Computer Rx: more harm than good?

Authors:  R Wall
Journal:  J Med Syst       Date:  1991-12       Impact factor: 4.460

Review 8.  Healthcare economics of bladder cancer: cost-enhancing and cost-reducing factors.

Authors:  Katia Noyes; Eric A Singer; Edward M Messing
Journal:  Curr Opin Urol       Date:  2008-09       Impact factor: 2.309

9.  Measuring the costs of outreach motivational interviewing for smoking cessation and relapse prevention among low-income pregnant women.

Authors:  Jennifer Prah Ruger; Karen M Emmons; Margaret H Kearney; Milton C Weinstein
Journal:  BMC Pregnancy Childbirth       Date:  2009-09-23       Impact factor: 3.007

10.  Simulation of the cost-effectiveness of malaria vaccines.

Authors:  Fabrizio Tediosi; Nicolas Maire; Melissa Penny; Alain Studer; Thomas A Smith
Journal:  Malar J       Date:  2009-06-08       Impact factor: 2.979

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.